Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Biologics, Cell & Gene Therapies, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.2.35, USP <785>

Therapeutic Modalities:

Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Small Molecules

Development Phases:

Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.9.12

Therapeutic Modalities:

Biologics, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

Ph. Eur. 2.9.31, USP <429>

Therapeutic Modalities:

Small Molecules

Development Phases:

Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.9.38 or USP <786>

Therapeutic Modalities:

Biologics, Cell & Gene Therapies, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.9.19, USP <788>

Therapeutic Modalities:

Biologics, Cell & Gene Therapies, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.9.19, USP <788>, USP <789>

Therapeutic Modalities:

Biologics, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.9.20

Therapeutic Modalities:

Biologics, Cell & Gene Therapies, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.2.3 or USP <791>

Therapeutic Modalities:

Biologics, Small Molecules

Development Phases:

Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical

Quality Standard:

non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Biologics

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Biologics, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP

Therapeutic Modalities:

Small Molecules

Development Phases:

Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.2.7 or USP <781>

Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)